Basic and clinical aspects of melatonin in the gastrointestinal tract. New advancements and future perspectives

Current Pharmaceutical Design

Volumn 20, Issue 30, 2014, Pages 4785-4787

  Brzozowski, Thomas ^a   Jaworek, Jolanta ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSEROTONIN METHYLTRANSFERASE; AGOMELATINE; ARALKYLAMINE ACETYLTRANSFERASE; MELATONIN; MELATONIN RECEPTOR; REACTIVE OXYGEN METABOLITE; SCAVENGER; SEROTONIN; CATALASE; GLUTATHIONE PEROXIDASE; HEAT SHOCK PROTEIN 70; PANCREAS ENZYME; SUPEROXIDE DISMUTASE;

ACUTE PANCREATITIS; AUTOPHAGY; CIRCADIAN RHYTHM; CLINICAL FEATURE; CLINICAL STUDY; CROHN DISEASE; EDITORIAL; ENDOPLASMIC RETICULUM; ENTEROCHROMAFFIN CELL; ENTEROHEPATIC CIRCULATION; ENTEROPATHY; EPITHELIUM; EXPERIMENTAL PANCREATITIS; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; GRAFT PRESERVATION; HUMAN; IN VITRO STUDY; INSULIN RELEASE; INTESTINE ABSORPTION; INTESTINE INJURY; LIVER RESECTION; METABOLISM; MICROBIOME; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE; STOMACH ACID SECRETION; THERAPY; ULCER HEALING; ULCERATIVE COLITIS; PHYSIOLOGY; APOPTOSIS; DEPRESSION; MICROCIRCULATION; PANCREAS CELL; PINEAL BODY; STOMACH MUCOSA;

GASTROINTESTINAL TRACT; HUMANS; MELATONIN;

EID: 84906218804     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612819666131119111201     Document Type: Editorial

References (30)

1. Harderland R, Madrid JA, Tan DX, Reiter RJ. Melatonin, the circardian multioscillator system and health: the need for a detailed analysis of peripheral melatonin signaling. J Pineal Res 2012; 52: 139-166.
2. Reiter RJ, Rosales-Corral SA, Manchester LC, Liu X, Tan DX. Melatonin in the biliary tract and liver: health implications. Curr Pharm Des 2014; 20(30): 4788-4801.
3. Reiter RJ, Rosales-Corral S, Coto-Montes A, et al. The photoperiod, circadian regulation and chronodisruption: the requisite interplay between the suprachiasmatic nuclei and the pineal and gut melatonin. J Physiol Pharmacol 2011; 62: 269-274.
4. Bertrand PP, Bertrand RL, Camello PJ, Pozo MJ Simultaneous measurement of serotonin and melatonin from the intestine of old mice: the effects of daily melatonin supplementation. J Pineal Res 2010; 49: 23-34.
5. Bertrand PP, Polglaze KE, Bertrand RL, Sandow SL, Pozo MJ. Detection of melatonin production from the intestinal epithelium using electrochemical methods Curr Pharm Des 2014; 20(30): 4802-4806.
6. Fuentes-Broto L, Miana-Mena FJ, Piedrafita E, et al. Melatonin protects against taurolithocholic-induced oxidative stress in rat liver. J Cell Biochem 2010; 110: 1219-1225.
7. Konturek PC, Brzozowska I, Targosz A, et al. Esophagoprotection mediated by exogenous and endogenous melatonin in an experimental model of reflux esophagitis. J Pineal Res 2013 Mar 10. doi: 10.1111/jpi.12048.
8. Patrick L. Gastroesophageal reflux disease (GERD): a review of conventional and alternative treatments. Altern Med Rev 2011; 16: 116-133.
9. Brzozowska I, Strzalka M, Drozdowicz D, Konturek SJ, Brzozowski T. Mechanisms of esophageal protection, gastroprotection and ulcer healing by melatonin. Implications for the therapeutic use of melatonin in gastroesophageal reflux disease (GERD) and peptic ulcer disease. Curr Pharm Des 2014; 20(30): 4807-4815.
10. Brzozowska I, Ptak-Belowska A, Pawlik M, et al. Mucosal strengthening activity of central and peripheral melatonin in the mechanism of gastric defense. J Physiol Pharmacol 2009; 60 (Suppl 7): 47-56.
11. Konturek PC, Konturek SJ, Burnat G, Brzozowski T, Brzozowska I, Reiter RJ. Dynamic physiological and molecular changes in gastric ulcer healing achieved by melatonin and its precursor L-tryptophan in rats. J Pineal Res 2008; 45:180-190.
12. Mozaffari S, Abdollahi M. Melatonin, a promising supplement in inflammatory bowel disease: a comprehensive review of evidences. Curr Pharm Des 2011; 17: 4372-4378.
13. Talero E, García-Mauriño S, Motilva V. Melatonin, autophagy and Intestinal Bowel Disease. Curr Pharm Des 2014; 20(30): 4816-4827.
14. Motilva V, Garcia-Maurino S, Talero E, Illanes M. New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin. J Pineal Res 2011; 51: 44-60.
15. Swanson GR, Burgess HJ, Keshavarzian A. Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare? Expert Rev Clin Immunol 2011; 7: 29-36.
16. Chojnacki C, Wisniewska-Jarosinska M, Kulig G, Majsterek I, Reiter RJ, Chojnacki J. Evaluation of enterochromaffin cells and melatonin secretion exponents in ulcerative colitis. World J Gastroenterol. 2013; 19: 3602-3607.
17. Chojnacki C, Walecka-Kapica E, Mokwinska M, et al. Influence of tianeptine on melatonin homeostasis and psychosomatic symptoms in patients with irritable bowel syndrome. J Physiol Pharmacol. 2013; 64: 177-183.
18. Zaouali MA, Boncompagni E, Reiter RJ, et al. AMPK involvement in endoplasmic reticulum stress and autophagy modulation after fatty liver graft preservation: a role for melatonin and trimetazidine coctail. J Pineal Res 2013 March 28. doi: 10.1111/jpi.12051.
19. Talero E, Avila-Roman J, Motilva V Chemoprevention with phytonutrients and microalgae products in chronic inflammation and colon cancer. Curr Pharm Des 2012; 18: 3939-3965.
20. Chojnacki C, Walecka-Kapica E, Romanowski M, Chojnacki J, Klupinska G. Protective role of melatonin in liver damage. Curr Pharm Des 2014; 20(30): 4828-4833.
21. Jaworek J, Nawrot-Porabka K, Leja-Szpak A, Konturek SJ. Brain-gut axis in the modulation of pancreatic enzyme secretion. J Physiol Pharmacol 2010; 61: 523-531.
22. Jaworek J, Leja-Szpak A, Kot M et al. The role of melatonin in pancreatic protection: Could melatonin be used in the treatment of acute pancreatitis? Curr Pharm Des 2014; 20(30): 4834-4840.
23. Leja-Szpak A, Jaworek J, Pierzchalski P, Reiter RJ. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). J Pineal Res 2010; 49: 248-255.
24. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A review of the multiple actions of melatonin on the immune system. Endocrine 2005; 27: 189-200.
25. Mauriz JL, Collado PS, Veneroso C, Reiter RJ, Gonzalez-Gallego J. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and perspectives. J Pineal Res 2013; 54: 1-14.
26. Lardone PJ, Álvarez-Sánchez N, Guerrero JM, Carrillo-Vico A. Melatonin and glucose metabolism: clinical relevance. Curr Pharm Des 2014; 20(30): 4841-4853.
27. Rami M, Landagaray E, Ettaoussi M, et al. Novel conformationally constrained analogues of agomelatine as new melatoninergic ligands. Molecules 2012, 24: 154-166.
28. Ettaoussi M, Sabaouni A, Pérès B, et al. Synthesis and pharmacological evaluation of a series of the agomelatine analogues as melatonin MT1 /MT2 agonist and 5-HT2C antagonist. Chem Med Chem. 2013 Sep 12. doi: 10.1002/cmdc.201300294.
29. Morellato L, Lefas-Le Gall M, Langlois M, et al. Synthesis of new N-(arylcyclopropyl)acetamides and N-(arylvinyl)acetamides as conformationally-restricted ligands for melatonin receptors. Bioorg Med Chem Lett. 2013; 23: 430-434.
30. Konturek PC, Brzozowski T, Konturek SJ. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol 2011; 62: 591-599.